Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Outlook Therapeutics, Inc. - Common Stock (NQ:OTLK)

2.410 -0.290 (-10.74%)
Streaming Delayed Price Updated: 3:53 PM EDT, Aug 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,972,972
Open 2.790
Bid (Size) 2.400 (15)
Ask (Size) 2.410 (9)
Prev. Close 2.700
Today's Range 2.210 - 2.790
52wk Range 0.8700 - 8.320
Shares Outstanding 43,479,051
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga

Performance

YTD
+17.0%
+17.0%
1 Month
+19.9%
+19.9%
3 Month
+49.7%
+49.7%
6 Month
+62.8%
+62.8%
1 Year
-68.6%
-68.6%

More News

Read More
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
Top 3 Health Care Stocks That Could Blast Off This Month
Via Benzinga
Outlook Therapeutics Reports Q3 Revenue
Via The Motley Fool
JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live
Via ACCESS Newswire
Rubrik To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Discover the top movers in Friday's pre-market session.
Via Chartmill
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities
Via FinancialNewsMedia
Topics Artificial Intelligence
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities
From FN Media Group LLC
Via GlobeNewswire
Thursday's after hours session: top gainers and losers
Via Chartmill
Coinbase To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug
Via Benzinga
This Kohl's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Nasdaq Down Over 100 Points; HP Shares Plunge
Via Benzinga
Dow Falls Over 100 Points; US Crude Oil Stocks Decline
Via Benzinga
Topics Stocks
US Stocks Mixed; Economy Grows By 2.8% In Q3
Via Benzinga
Topics Economy
Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Lower On Wednesday?
Via Benzinga
OUTLOOK ALERT: Bragar Eagel & Squire, P.C. is Investigating Outlook Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
OTLK Stock Earnings: Outlook Therapeutics Beats EPS for Q3 2024
Via InvestorPlace
3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices
Via MarketBeat

Frequently Asked Questions

Is Outlook Therapeutics, Inc. - Common Stock publicly traded?
Yes, Outlook Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Outlook Therapeutics, Inc. - Common Stock trade on?
Outlook Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Outlook Therapeutics, Inc. - Common Stock?
The ticker symbol for Outlook Therapeutics, Inc. - Common Stock is OTLK on the Nasdaq Stock Market
What is the current price of Outlook Therapeutics, Inc. - Common Stock?
The current price of Outlook Therapeutics, Inc. - Common Stock is 2.410
When was Outlook Therapeutics, Inc. - Common Stock last traded?
The last trade of Outlook Therapeutics, Inc. - Common Stock was at 08/27/25 03:53 PM ET
What is the market capitalization of Outlook Therapeutics, Inc. - Common Stock?
The market capitalization of Outlook Therapeutics, Inc. - Common Stock is 104.78M
How many shares of Outlook Therapeutics, Inc. - Common Stock are outstanding?
Outlook Therapeutics, Inc. - Common Stock has 105M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.